Spiroindolinone as a DDR1 inhibitor

摘要

The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, a process for their preparation, a pharmaceutical composition comprising them, and their use as a medicament. [Selection figure] None